Related Experiment Video
Updated: Jun 28, 2026
09:14
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr virus LF2: an antagonist to type I interferon
Liguo Wu1, Even Fossum, Chul Hyun Joo
1Department of Microbiology and Molecular Genetics, Tumor Virology Division, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772, USA.
Journal of Virology
|November 7, 2008
Summary
Epstein-Barr virus (EBV) uses its LF2 protein to block the host
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- The interferon (IFN)-mediated antiviral pathway, regulated by IFN regulatory factors (IRFs), is crucial for host defense against viral infections.
- Viruses often evolve mechanisms to evade host innate immunity, including the IFN pathway, to ensure their replication and survival.
- Epstein-Barr virus (EBV), a human tumor-inducing herpesvirus, has incompletely understood strategies for evading host IFN-mediated immunity.
Purpose of the Study:
- To identify Epstein-Barr virus (EBV) genes that interfere with host IFN signal transduction.
- To elucidate the molecular mechanism by which EBV evades the host's innate immune response.
Main Methods:
- Screening of EBV open reading frames for their ability to inhibit IFN-alpha/beta-mediated luciferase expression.
- Assessing the interaction between EBV proteins and IRF7.
- Investigating the impact of EBV LF2 protein on IRF7 dimerization and IFN-alpha production.
Main Results:
- EBV LF2 tegument protein was identified as an inhibitor of IFN signal transduction.
- EBV LF2 specifically interacts with the central inhibitory association domain of IRF7.
- This interaction inhibits IRF7 dimerization, leading to suppressed IFN-alpha production and impaired IFN-mediated immunity.
Conclusions:
- EBV LF2 protein represents a novel viral immune evasion strategy.
- The mechanism involves direct interference with the host's IRF7-mediated innate immune response.
- Understanding this interaction is key to comprehending EBV's pathogenesis and host immune evasion tactics.
More Related Videos
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...